NXTS N2OFF, Inc.
Healthcare$4.48+1.36%ClosedMarket Cap: $253,546
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
213.02
P/S
-65.12
EV/EBITDA
-0.10
DCF Value
$20.46
FCF Yield
-102.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
266.7%
Operating Margin
10362.1%
Net Margin
15562.1%
ROE
-94.1%
ROA
-62.6%
ROIC
-45.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.2M | $-7.5M | $— | — |
| Q4 null | $-68.0K | 100.0% | $-587.0K | $1.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-5.0M | $-4.0M | $— | — |
| Q3 null | $2.0K | 0.0% | $-1.3M | $429.0K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.8M | $-4.5M | $— | — |
| Q1 null | $66.0K | 78.8% | $-619.0K | $-1.2M | $— | — |
| Q4 null | $140.5K | 60.9% | $-1.0M | $-1.4M | $— | — |
| FY null | $210.0K | 15.7% | $-4.0M | $-5.2M | $— | — |
| Q3 null | $9.0K | -755.6% | $-1.4M | $-2.1M | $— | — |
| Q2 null | $17.0K | 64.7% | $-789.0K | $-766.0K | $— | — |
| Q1 null | $43.8K | 35.0% | $-899.1K | $-769.6K | $— | — |
| Q4 null | $105.8K | 113.3% | $-2.2M | $-1.7M | $— | — |